カテゴリー： 世界, 医療/バイオ, Market Monitor Global

世界の帯状疱疹ワクチン市場予測2023-2029：生、組換え

【英語タイトル】Zoster Vaccine Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料（MMG23LY8765）・商品コード：MMG23LY8765
・発行会社（調査会社）：Market Monitor Global
・発行日：2023年7月
・ページ数：78
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野：医薬品＆ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の帯状疱疹ワクチン市場規模と予測を収録しています。・世界の帯状疱疹ワクチン市場：売上、2018年-2023年、2024年-2029年
・世界の帯状疱疹ワクチン市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の帯状疱疹ワクチン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「生」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

帯状疱疹ワクチンのグローバル主要企業は、GSK、 Merck、 Sanofi Pasteurなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、帯状疱疹ワクチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の帯状疱疹ワクチン市場：タイプ別、2018年-2023年、2024年-2029年
世界の帯状疱疹ワクチン市場：タイプ別市場シェア、2022年
・生、組換え

世界の帯状疱疹ワクチン市場：用途別、2018年-2023年、2024年-2029年
世界の帯状疱疹ワクチン市場：用途別市場シェア、2022年
・政府機関、民間、その他

世界の帯状疱疹ワクチン市場：地域・国別、2018年-2023年、2024年-2029年
世界の帯状疱疹ワクチン市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における帯状疱疹ワクチンのグローバル売上、2018年-2023年
・主要企業における帯状疱疹ワクチンのグローバル売上シェア、2022年
・主要企業における帯状疱疹ワクチンのグローバル販売量、2018年-2023年
・主要企業における帯状疱疹ワクチンのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
GSK、 Merck、 Sanofi Pasteur

*************************************************************

・調査・分析レポートの概要
帯状疱疹ワクチン市場の定義
市場セグメント
世界の帯状疱疹ワクチン市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の帯状疱疹ワクチン市場規模
世界の帯状疱疹ワクチン市場規模：2022年 VS 2029年
世界の帯状疱疹ワクチン市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの帯状疱疹ワクチンの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の帯状疱疹ワクチン製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：生、組換え
帯状疱疹ワクチンのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：政府機関、民間、その他
帯状疱疹ワクチンの用途別グローバル売上・予測

・地域別市場分析
地域別帯状疱疹ワクチン市場規模 2022年と2029年
地域別帯状疱疹ワクチン売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
GSK、 Merck、 Sanofi Pasteur
...

Zoster vaccines are two vaccines that have been shown to reduce the rates of herpes zoster (also known as shingles). 
This report aims to provide a comprehensive presentation of the global market for Zoster Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Zoster Vaccine. This report contains market size and forecasts of Zoster Vaccine in global, including the following market information:
Global Zoster Vaccine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Zoster Vaccine Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Zoster Vaccine companies in 2022 (%)
The global Zoster Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Live Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Zoster Vaccine include GSK, Merck and Sanofi Pasteur, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Zoster Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Zoster Vaccine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Zoster Vaccine Market Segment Percentages, by Type, 2022 (%)
Live
Recombinant
Global Zoster Vaccine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Zoster Vaccine Market Segment Percentages, by Application, 2022 (%)
Government Institution
Private Sector
Other
Global Zoster Vaccine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Zoster Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Zoster Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Zoster Vaccine revenues share in global market, 2022 (%)
Key companies Zoster Vaccine sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Zoster Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GSK
Merck
Sanofi Pasteur
Outline of Major Chapters:
Chapter 1: Introduces the definition of Zoster Vaccine, market overview.
Chapter 2: Global Zoster Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Zoster Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Zoster Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Zoster Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Zoster Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Zoster Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Zoster Vaccine Overall Market Size
2.1 Global Zoster Vaccine Market Size: 2022 VS 2029
2.2 Global Zoster Vaccine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Zoster Vaccine Sales: 2018-2029
3 Company Landscape
3.1 Top Zoster Vaccine Players in Global Market
3.2 Top Global Zoster Vaccine Companies Ranked by Revenue
3.3 Global Zoster Vaccine Revenue by Companies
3.4 Global Zoster Vaccine Sales by Companies
3.5 Global Zoster Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Zoster Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Zoster Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Zoster Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Zoster Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Zoster Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Zoster Vaccine Market Size Markets, 2022 & 2029
4.1.2 Live
4.1.3 Recombinant
4.2 By Type – Global Zoster Vaccine Revenue & Forecasts
4.2.1 By Type – Global Zoster Vaccine Revenue, 2018-2023
4.2.2 By Type – Global Zoster Vaccine Revenue, 2024-2029
4.2.3 By Type – Global Zoster Vaccine Revenue Market Share, 2018-2029
4.3 By Type – Global Zoster Vaccine Sales & Forecasts
4.3.1 By Type – Global Zoster Vaccine Sales, 2018-2023
4.3.2 By Type – Global Zoster Vaccine Sales, 2024-2029
4.3.3 By Type – Global Zoster Vaccine Sales Market Share, 2018-2029
4.4 By Type – Global Zoster Vaccine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Zoster Vaccine Market Size, 2022 & 2029
5.1.2 Government Institution
5.1.3 Private Sector
5.1.4 Other
5.2 By Application – Global Zoster Vaccine Revenue & Forecasts
5.2.1 By Application – Global Zoster Vaccine Revenue, 2018-2023
5.2.2 By Application – Global Zoster Vaccine Revenue, 2024-2029
5.2.3 By Application – Global Zoster Vaccine Revenue Market Share, 2018-2029
5.3 By Application – Global Zoster Vaccine Sales & Forecasts
5.3.1 By Application – Global Zoster Vaccine Sales, 2018-2023
5.3.2 By Application – Global Zoster Vaccine Sales, 2024-2029
5.3.3 By Application – Global Zoster Vaccine Sales Market Share, 2018-2029
5.4 By Application – Global Zoster Vaccine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Zoster Vaccine Market Size, 2022 & 2029
6.2 By Region – Global Zoster Vaccine Revenue & Forecasts
6.2.1 By Region – Global Zoster Vaccine Revenue, 2018-2023
6.2.2 By Region – Global Zoster Vaccine Revenue, 2024-2029
6.2.3 By Region – Global Zoster Vaccine Revenue Market Share, 2018-2029
6.3 By Region – Global Zoster Vaccine Sales & Forecasts
6.3.1 By Region – Global Zoster Vaccine Sales, 2018-2023
6.3.2 By Region – Global Zoster Vaccine Sales, 2024-2029
6.3.3 By Region – Global Zoster Vaccine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Zoster Vaccine Revenue, 2018-2029
6.4.2 By Country – North America Zoster Vaccine Sales, 2018-2029
6.4.3 US Zoster Vaccine Market Size, 2018-2029
6.4.4 Canada Zoster Vaccine Market Size, 2018-2029
6.4.5 Mexico Zoster Vaccine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Zoster Vaccine Revenue, 2018-2029
6.5.2 By Country – Europe Zoster Vaccine Sales, 2018-2029
6.5.3 Germany Zoster Vaccine Market Size, 2018-2029
6.5.4 France Zoster Vaccine Market Size, 2018-2029
6.5.5 U.K. Zoster Vaccine Market Size, 2018-2029
6.5.6 Italy Zoster Vaccine Market Size, 2018-2029
6.5.7 Russia Zoster Vaccine Market Size, 2018-2029
6.5.8 Nordic Countries Zoster Vaccine Market Size, 2018-2029
6.5.9 Benelux Zoster Vaccine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Zoster Vaccine Revenue, 2018-2029
6.6.2 By Region – Asia Zoster Vaccine Sales, 2018-2029
6.6.3 China Zoster Vaccine Market Size, 2018-2029
6.6.4 Japan Zoster Vaccine Market Size, 2018-2029
6.6.5 South Korea Zoster Vaccine Market Size, 2018-2029
6.6.6 Southeast Asia Zoster Vaccine Market Size, 2018-2029
6.6.7 India Zoster Vaccine Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Zoster Vaccine Revenue, 2018-2029
6.7.2 By Country – South America Zoster Vaccine Sales, 2018-2029
6.7.3 Brazil Zoster Vaccine Market Size, 2018-2029
6.7.4 Argentina Zoster Vaccine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Zoster Vaccine Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Zoster Vaccine Sales, 2018-2029
6.8.3 Turkey Zoster Vaccine Market Size, 2018-2029
6.8.4 Israel Zoster Vaccine Market Size, 2018-2029
6.8.5 Saudi Arabia Zoster Vaccine Market Size, 2018-2029
6.8.6 UAE Zoster Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 GSK
7.1.1 GSK Company Summary
7.1.2 GSK Business Overview
7.1.3 GSK Zoster Vaccine Major Product Offerings
7.1.4 GSK Zoster Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 GSK Key News & Latest Developments
7.2 Merck
7.2.1 Merck Company Summary
7.2.2 Merck Business Overview
7.2.3 Merck Zoster Vaccine Major Product Offerings
7.2.4 Merck Zoster Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 Merck Key News & Latest Developments
7.3 Sanofi Pasteur
7.3.1 Sanofi Pasteur Company Summary
7.3.2 Sanofi Pasteur Business Overview
7.3.3 Sanofi Pasteur Zoster Vaccine Major Product Offerings
7.3.4 Sanofi Pasteur Zoster Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 Sanofi Pasteur Key News & Latest Developments
8 Global Zoster Vaccine Production Capacity, Analysis
8.1 Global Zoster Vaccine Production Capacity, 2018-2029
8.2 Zoster Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Zoster Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Zoster Vaccine Supply Chain Analysis
10.1 Zoster Vaccine Industry Value Chain
10.2 Zoster Vaccine Upstream Market
10.3 Zoster Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Zoster Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Zoster Vaccine in Global Market
Table 2. Top Zoster Vaccine Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Zoster Vaccine Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Zoster Vaccine Revenue Share by Companies, 2018-2023
Table 5. Global Zoster Vaccine Sales by Companies, (K Units), 2018-2023
Table 6. Global Zoster Vaccine Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Zoster Vaccine Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Zoster Vaccine Product Type
Table 9. List of Global Tier 1 Zoster Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Zoster Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Zoster Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Zoster Vaccine Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Zoster Vaccine Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Zoster Vaccine Sales (K Units), 2018-2023
Table 15. By Type - Global Zoster Vaccine Sales (K Units), 2024-2029
Table 16. By Application – Global Zoster Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Zoster Vaccine Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Zoster Vaccine Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Zoster Vaccine Sales (K Units), 2018-2023
Table 20. By Application - Global Zoster Vaccine Sales (K Units), 2024-2029
Table 21. By Region – Global Zoster Vaccine Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Zoster Vaccine Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Zoster Vaccine Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Zoster Vaccine Sales (K Units), 2018-2023
Table 25. By Region - Global Zoster Vaccine Sales (K Units), 2024-2029
Table 26. By Country - North America Zoster Vaccine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Zoster Vaccine Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Zoster Vaccine Sales, (K Units), 2018-2023
Table 29. By Country - North America Zoster Vaccine Sales, (K Units), 2024-2029
Table 30. By Country - Europe Zoster Vaccine Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Zoster Vaccine Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Zoster Vaccine Sales, (K Units), 2018-2023
Table 33. By Country - Europe Zoster Vaccine Sales, (K Units), 2024-2029
Table 34. By Region - Asia Zoster Vaccine Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Zoster Vaccine Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Zoster Vaccine Sales, (K Units), 2018-2023
Table 37. By Region - Asia Zoster Vaccine Sales, (K Units), 2024-2029
Table 38. By Country - South America Zoster Vaccine Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Zoster Vaccine Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Zoster Vaccine Sales, (K Units), 2018-2023
Table 41. By Country - South America Zoster Vaccine Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Zoster Vaccine Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Zoster Vaccine Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Zoster Vaccine Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Zoster Vaccine Sales, (K Units), 2024-2029
Table 46. GSK Company Summary
Table 47. GSK Zoster Vaccine Product Offerings
Table 48. GSK Zoster Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. GSK Key News & Latest Developments
Table 50. Merck Company Summary
Table 51. Merck Zoster Vaccine Product Offerings
Table 52. Merck Zoster Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Merck Key News & Latest Developments
Table 54. Sanofi Pasteur Company Summary
Table 55. Sanofi Pasteur Zoster Vaccine Product Offerings
Table 56. Sanofi Pasteur Zoster Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Sanofi Pasteur Key News & Latest Developments
Table 58. Zoster Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 59. Global Zoster Vaccine Capacity Market Share of Key Manufacturers, 2021-2023
Table 60. Global Zoster Vaccine Production by Region, 2018-2023 (K Units)
Table 61. Global Zoster Vaccine Production by Region, 2024-2029 (K Units)
Table 62. Zoster Vaccine Market Opportunities & Trends in Global Market
Table 63. Zoster Vaccine Market Drivers in Global Market
Table 64. Zoster Vaccine Market Restraints in Global Market
Table 65. Zoster Vaccine Raw Materials
Table 66. Zoster Vaccine Raw Materials Suppliers in Global Market
Table 67. Typical Zoster Vaccine Downstream
Table 68. Zoster Vaccine Downstream Clients in Global Market
Table 69. Zoster Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Zoster Vaccine Segment by Type in 2022
Figure 2. Zoster Vaccine Segment by Application in 2022
Figure 3. Global Zoster Vaccine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Zoster Vaccine Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Zoster Vaccine Revenue, 2018-2029 (US$, Mn)
Figure 7. Zoster Vaccine Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Zoster Vaccine Revenue in 2022
Figure 9. By Type - Global Zoster Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Zoster Vaccine Revenue Market Share, 2018-2029
Figure 11. By Type - Global Zoster Vaccine Sales Market Share, 2018-2029
Figure 12. By Type - Global Zoster Vaccine Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Zoster Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Zoster Vaccine Revenue Market Share, 2018-2029
Figure 15. By Application - Global Zoster Vaccine Sales Market Share, 2018-2029
Figure 16. By Application - Global Zoster Vaccine Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Zoster Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Zoster Vaccine Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Zoster Vaccine Revenue Market Share, 2018-2029
Figure 20. By Region - Global Zoster Vaccine Sales Market Share, 2018-2029
Figure 21. By Country - North America Zoster Vaccine Revenue Market Share, 2018-2029
Figure 22. By Country - North America Zoster Vaccine Sales Market Share, 2018-2029
Figure 23. US Zoster Vaccine Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Zoster Vaccine Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Zoster Vaccine Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Zoster Vaccine Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Zoster Vaccine Sales Market Share, 2018-2029
Figure 28. Germany Zoster Vaccine Revenue, (US$, Mn), 2018-2029
Figure 29. France Zoster Vaccine Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Zoster Vaccine Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Zoster Vaccine Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Zoster Vaccine Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Zoster Vaccine Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Zoster Vaccine Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Zoster Vaccine Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Zoster Vaccine Sales Market Share, 2018-2029
Figure 37. China Zoster Vaccine Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Zoster Vaccine Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Zoster Vaccine Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Zoster Vaccine Revenue, (US$, Mn), 2018-2029
Figure 41. India Zoster Vaccine Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Zoster Vaccine Revenue Market Share, 2018-2029
Figure 43. By Country - South America Zoster Vaccine Sales Market Share, 2018-2029
Figure 44. Brazil Zoster Vaccine Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Zoster Vaccine Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Zoster Vaccine Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Zoster Vaccine Sales Market Share, 2018-2029
Figure 48. Turkey Zoster Vaccine Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Zoster Vaccine Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Zoster Vaccine Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Zoster Vaccine Revenue, (US$, Mn), 2018-2029
Figure 52. Global Zoster Vaccine Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Zoster Vaccine by Region, 2022 VS 2029
Figure 54. Zoster Vaccine Industry Value Chain
Figure 55. Marketing Channels


★調査レポート[世界の帯状疱疹ワクチン市場予測2023-2029：生、組換え] (コード：MMG23LY8765)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の帯状疱疹ワクチン市場予測2023-2029：生、組換え]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の10価肺炎球菌結合型ワクチン市場予測2023-2029：単回投与バイアル、プレフィルドシリンジ
  • 世界の小児用インフルエンザワクチン市場予測2023-2029：点鼻薬、注射
  • 世界の注射用インフルエンザワクチン市場予測2023-2029：価インフルエンザワクチン、4価インフルエンザワクチン
  • 世界の水痘ウイルス生ワクチン市場予測2023-2029：子供、大人
  • 世界のヒト注射用インフルエンザワクチン市場予測2023-2029：3価インフルエンザワクチン、4価インフルエンザワクチン

    • ◆H&Iグローバルリサーチのお客様（例）◆